Skip to main content
. 2018 Sep 4;35(1):161–170. doi: 10.1007/s10554-018-1441-y

Table 3.

CMR parameters pre- and post-TAVR interventions in all patients

All patients Baseline
n = 85
6 m follow up
n = 85
p value
LV mass (g) 138.2 ± 35.3 109.9 ± 31 < 0.001
LVEDV (ml) 179 ± 49.3 166.4 ± 44.2 < 0.001
LVESV (ml) 84.2 ± 43.5 75.7 ± 35.6 0.006
LVSV (ml) 94.5 ± 22.5 90.7 ± 18.7 0.04
LVEF (%) 54.8 ± 12.2 56.3 ± 10.6 0.10
RVSV (ml) 74.3 ± 18.4 78.7 ± 20.4 0.04
RVEF (%) 54.2 ± 9.5 55.4 ± 10.1 0.20
LA volume (ml) 131.8 ± 45.0 119.1 ± 41.3 < 0.001
MR volume (ml) 22.4 ± 15.0 13.7 ± 12.9 < 0.001
MR fraction (%) 22.6 ± 13.3 14.5 ± 12.4 < 0.001
MR classifications (n)
 Mitral regurgitation %
  MR none (0%) 8 14
  MR mild (5–15%) 20 35
  MR moderate (16–25%) 19 20
  MR moderate-severe (26–48%) 38 16 < 0.001
Classifications of LGE, n (%)
 None 24 (28) 28 (33)
 Infarct pattern 19 (22) 23 (27)
 Non-infarct pattern 33 (39) 24 (28) 0.23
 Mixed 4 (5) 3 (4)
 Not done 5 (6) 7 (8)
Presence of LGE, n (%)
 LGE present 56 (66) 50 (59)
 LGE absent 24 (28) 28 (33)
 LGE not done 5 (6) 7 (8)

Data as mean ± SD, n (%)

LA left atrial, LGE late gadolinium enhancement, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, LVSV left ventricular stroke volume, MR mitral regurgitation, RVEF right ventricular ejection fraction, RVSV right ventricular stroke volume